CompaniesLidak Pharmaceuticals

Lidak Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

2

As Collaborator

4

Total Enrollment

3,378

By Phase

PHASE4: 3PHASE3: 2

By Status

COMPLETED: 4UNKNOWN: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Today
NCT01678430
NCT03088449
Hover over trial bars to see details

Recent Trials

NCT02388373Collaborator
A Guideline Approach to Therapy Step-down Utilising Flutiform Change and Step-down
PHASE4Completed
225 participants
Started: Jul 31, 2014 · Completed: Mar 31, 2016
NCT03088449Collaborator
Personalising Anti-TNF Therapy in Crohns Disease (PANTS)
N/AUnknown
1,750 participants
Started: Mar 31, 2013 · Completed: Jul 30, 2019
NCT01678430Collaborator
A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment
PHASE3Unknown
670 participants
Started: Dec 31, 2011 · Completed: Dec 31, 2017
NCT00784810Lead Sponsor
A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis
PHASE4Completed
247 participants
Started: Feb 28, 2009 · Completed: Jun 30, 2011
NCT00324038Lead Sponsor
Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly
PHASE4Completed
219 participants
Started: Mar 31, 2006 · Completed: Dec 31, 2007
View all 6 trials →
Funding History (20)
8-K
Jan 13, 2015
Filing
8-K
Dec 2, 2014
Filing
8-K
Nov 28, 2014
Filing
8-K
Nov 12, 2014
Filing
8-K
Nov 7, 2014
Filing
8-K
Sep 25, 2014
Filing
8-K
Sep 15, 2014
Filing
8-K
Aug 5, 2014
Filing
8-K
May 7, 2014
Filing
8-K
May 6, 2014
Filing